Year All202320222021202020192018201720162015 Poseida Therapeutics to Host Third Annual Virtual R&D Day on February 22, 2023 February 8, 2023 Poseida Therapeutics Announces Board Change January 31, 2023 Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy for Hemophilia A at the 64th ASH Annual Meeting & Exposition December 11, 2022 Poseida Therapeutics to Present Early Data from Phase 1 Trials of P-MUC1C-ALLO1 and P-BCMA-ALLO1 at ESMO Immuno-Oncology 2022 Annual Congress December 6, 2022 Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2022 November 10, 2022 Poseida Therapeutics to Present at Two Upcoming Investor Conferences November 8, 2022 Poseida Therapeutics to Present at the ESMO Immuno-Oncology 2022 Annual Congress November 3, 2022 Poseida Therapeutics Announces Oral Presentation Highlighting P-FVIII-101 Gene Therapy at the 64th ASH Annual Meeting & Exposition November 3, 2022 Poseida Therapeutics to Present Trial in Progress Poster for Phase 1 P-MUC1C-ALLO1 Study at the Society for Immunotherapy of Cancer Annual Meeting October 5, 2022 Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference September 7, 2022
Poseida Therapeutics Presents Preclinical Data from P-FVIII-101 Gene Therapy for Hemophilia A at the 64th ASH Annual Meeting & Exposition December 11, 2022
Poseida Therapeutics to Present Early Data from Phase 1 Trials of P-MUC1C-ALLO1 and P-BCMA-ALLO1 at ESMO Immuno-Oncology 2022 Annual Congress December 6, 2022
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2022 November 10, 2022
Poseida Therapeutics Announces Oral Presentation Highlighting P-FVIII-101 Gene Therapy at the 64th ASH Annual Meeting & Exposition November 3, 2022
Poseida Therapeutics to Present Trial in Progress Poster for Phase 1 P-MUC1C-ALLO1 Study at the Society for Immunotherapy of Cancer Annual Meeting October 5, 2022
Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference September 7, 2022